Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27346105 | 0.85 | IDO1 (0.61) | TDP1IDO1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6341147 | 0.78 | ALDH1A1 (0.52) | TDP1CA1CA2CA9IDO1 | |
| SCHEMBL198134 | 0.78 | TSHR (0.52) | TDP1CA1CA2CA9IDO1 | |
| SCHEMBL7038839 | 0.76 | CA1 (0.50) | TDP1CA1CA2CA9IDO1 | |
| SCHEMBL21987926 | 0.76 | ALDH1A1 (0.50) | TDP1CA1CA2CA9IDO1 | |
| SCHEMBL29209150 | 0.75 | TAAR1 (0.50) | IDO1TAAR1LOXL2MAOAMAOB | |
| SCHEMBL29018028 | 0.75 | CYP1A2 (0.50) | TDP1IDO1ALOX15CYP2A6TAAR1 | |
| SCHEMBL5712931 | 0.75 | TDP1 (0.54) | TDP1CA1CA2CA9IDO1 | |
| SCHEMBL5946547 | 0.74 | CA1 (0.48) | TDP1CA1CA2CA9IDO1 | |
| SCHEMBL5733114 | 0.74 | CA1 (0.48) | TDP1CA1CA2CA9IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115772063-B | Preparation process and method of chloro (bromo) styrene | 中国科学院大连化学物理研究所 | 2025-04-29 | — | — | CN | claimed |
| CN-116023231-A | Method for preparing chloro (bromo) styrene by dehydration of chloro (bromo) phenethyl alcohol | 中国科学院大连化学物理研究所 | 2023-04-28 | — | — | CN | claimed |
| CN-115772063-A | Preparation process and method of chloro (bromo) styrene | 中国科学院大连化学物理研究所 | 2023-03-10 | — | — | CN | claimed |
| CN-111233908-A | Benzoxaborol-1-ol compound and preparation method and application thereof | 南京农业大学 | 2020-06-05 | — | — | CN | claimed |
| CN-107857702-A | A kind of preparation method of bilastine intermediate | 重庆华邦制药有限公司 | 2018-03-30 | — | — | CN | claimed |
| CN-105039428-A | Method for producing (S)-bromophenethyl alcohol with melanomyces | UNIV QINGDAO SCIENCE & TECHNOLOGY | 2015-11-11 | — | — | CN | claimed |
| CN-115772063-B | Preparation process and method of chloro (bromo) styrene | 中国科学院大连化学物理研究所 | 2025-04-29 | — | — | CN | disclosed |
| CN-115724719-B | Method for preparing halohydrin | 中国石油化工股份有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-115073353-B | Lignan derivative, preparation method thereof, pharmaceutical composition and application thereof | 中国医学科学院药物研究所 | 2024-05-14 | — | — | CN | disclosed |
| CN-116023231-A | Method for preparing chloro (bromo) styrene by dehydration of chloro (bromo) phenethyl alcohol | 中国科学院大连化学物理研究所 | 2023-04-28 | — | — | CN | disclosed |
| CN-116023231-A | Method for preparing chloro (bromo) styrene by dehydration of chloro (bromo) phenethyl alcohol | 中国科学院大连化学物理研究所 | 2023-04-28 | — | — | CN | disclosed |
| CN-116023231-A | Method for preparing chloro (bromo) styrene by dehydration of chloro (bromo) phenethyl alcohol | 中国科学院大连化学物理研究所 | 2023-04-28 | — | — | CN | disclosed |
| CN-115772063-A | Preparation process and method of chloro (bromo) styrene | 中国科学院大连化学物理研究所 | 2023-03-10 | — | — | CN | disclosed |
| WO-2006081345-A1 | CHROMOPHORE AND POLYMER CAPABLE OF DETECTING THE PRESENCE OF VARIOUS NEUROTOXINS AND METHOD OF USE | NORTH DAKOTA STATE UNIVERSITY (US) | 2006-08-03 | — | — | WO | disclosed |
| US-6956050-B2 | Imidazole compounds as anti-inflammatory and analgesic agents | PFIZER, INC. (US) | 2005-10-18 | — | — | US | disclosed |
| EP-1494667-A1 | IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS | Pfizer Japan Inc. (JP) | 2005-01-12 | — | — | EP | disclosed |
| US-20030220372-A1 | Imidazole compounds as anti-inflammatory and analgesic agents | HIRANO MISATO (JP) | 2003-11-27 | — | — | US | disclosed |
| WO-2003086390-A1 | IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS | PFIZER JAPAN INC. (JP) | 2003-10-23 | — | — | WO | disclosed |
| EP-0369279-A1 | 7-oxabicycloheptane imino interphenyleneoxy substituted prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease | E.R. SQUIBB & SONS, INC. (US) | 1990-05-23 | — | — | EP | disclosed |
| US-4883809-A | 7-Oxabicycloheptane imino interphenyleneoxy substituted prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease | E. R. SQUIBB & SONS, INC. | 1989-11-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220372-A1 | Imidazole compounds as anti-inflammatory and analgesic agents | PTGS1, PTGS2, PTGES | TDP1 4442/4885CA1 2155/4885CA2 608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.